Utilisation disease-modifying anti-rheumatic drugs (DMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world cohort studyFirst published 24/01/2020 Last updated 24/01/2020 EU PAS number: EUPAS33253StudyOngoing